Will Vaccine Manufacturers' Windfalls Continue Beyond 2022?
We think the COVID-19 treatment market will have more longevity.
United States Astrazeneca Evusheld Walter Reed Roche Tamiflu Preventive Therapies Dont Forecast Further Doses Beyond
Source: morningstar.com